Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: A prospective study

BACKGROUND: The contraceptive skin patch (CSP) accepted by the U.S. FDA in 2001 includes ethinylestradiol and norelgestromine, whereas the subdermal contraceptive implant (SCI) has etonogestrel and is also approved by the FDA. In Mexico, both are now widely used for contraception but their effects o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hernandez-Juarez, Jesus, Garcia-Latorre, Ethel A, Moreno-Hernandez, Manuel, Moran-Perez, Jose Fernando, Rodriguez-Escobedo, Miguel Angel, Cogque-Hernandez, Gerardo, Julián-Nacer, Rubén, Hernandez-Giron, Xochitl, Palafox-Gomez, Rosalia, Isordia-Salas, Irma, Majluf-Cruz, Abraham
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4044294/
https://ncbi.nlm.nih.gov/pubmed/24767248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-4755-11-33
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars